These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8551892)

  • 1. Safety of modern oral contraceptives.
    Henzl MR
    Lancet; 1996 Jan; 347(8996):257-8. PubMed ID: 8551892
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety of modern oral contraceptives. The International Committee for Research in Reproduction.
    Johannisson E
    Lancet; 1996 Jan; 347(8996):258. PubMed ID: 8551893
    [No Abstract]   [Full Text] [Related]  

  • 3. Safety of combined oral contraceptive pills.
    Cramer DW
    Lancet; 1996 Feb; 347(9000):546-8. PubMed ID: 8596297
    [No Abstract]   [Full Text] [Related]  

  • 4. Safety of modern oral contraceptives.
    Farmer R
    Lancet; 1996 Jan; 347(8996):259. PubMed ID: 8551895
    [No Abstract]   [Full Text] [Related]  

  • 5. Deep vein thrombophlebitis of a leg in a young female with heterozygous protein C deficiency taking oral contraceptives.
    Simioni P; Lazzaro AR; Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(3):443-5. PubMed ID: 1703114
    [No Abstract]   [Full Text] [Related]  

  • 6. Safety of modern oral contraceptives.
    Donnelly RJ
    Lancet; 1996 Jan; 347(8996):260. PubMed ID: 8551899
    [No Abstract]   [Full Text] [Related]  

  • 7. Third generation oral contraceptives.
    Skegg DC
    BMJ; 2000 Jul; 321(7255):190-1. PubMed ID: 10903631
    [No Abstract]   [Full Text] [Related]  

  • 8. Oral contraceptives and venous thromboembolism.
    Graham A; Grieve F; Davie J; Glasier A
    Lancet; 1995 Nov; 346(8987):1430. PubMed ID: 7475846
    [No Abstract]   [Full Text] [Related]  

  • 9. European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12".
    Serfaty D; Wildemeersch D; Verougstraete A; Creatsas G
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():73-9. PubMed ID: 8574253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of idiopathic cerebral haemorrhage in women on oral contraceptives with differing progestagen components.
    Jick SS; Myers MW; Jick H
    Lancet; 1999 Jul; 354(9175):302-3. PubMed ID: 10440310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What is the risk of venous thromboembolism (VTE) among women taking third-generation oral contraceptives (OCs) in comparison with those taking contraceptives containing levonorgestrel?
    Meurer LN; Slawson JG
    J Fam Pract; 2001 Feb; 50(2):108. PubMed ID: 11219554
    [No Abstract]   [Full Text] [Related]  

  • 12. Comments on desogestrel and gestoden (3rd generation progestogens) and the incidence of thromboembolism.
    Lauritzen C
    Horm Metab Res; 1996 May; 28(5):245-7. PubMed ID: 8738115
    [No Abstract]   [Full Text] [Related]  

  • 13. Pregnancies and terminations after 1995 warning about third-generation oral contraceptives.
    Jick SS; Vasilakis C; Jick H
    Lancet; 1998 May; 351(9113):1404-5. PubMed ID: 9593415
    [No Abstract]   [Full Text] [Related]  

  • 14. Risk of acute myocardial infarction and low-dose combined oral contraceptives.
    Jick H; Jick S; Myers MW; Vasilakis C
    Lancet; 1996 Mar; 347(9001):627-8. PubMed ID: 8596366
    [No Abstract]   [Full Text] [Related]  

  • 15. Combined oral contraceptives, venous thromboembolism, and the problem of interpreting large but incomplete datasets.
    Dinger J; Shapiro S
    J Fam Plann Reprod Health Care; 2012 Jan; 38(1):2-6. PubMed ID: 22128104
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative metabolic effects of oral contraceptive preparations containing different progestagens. Effects of desogestrel + ethinylestradiol on the haemostatic balance.
    Rákóczi I; Gerö G; Demeter J; Gáti I
    Arzneimittelforschung; 1985; 35(3):630-3. PubMed ID: 3158320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sexual abstinence of thrombosis? Comment on the controversy regarding the "pill of the 3rd generation"].
    Strobel E
    Fortschr Med; 1995 Nov; 113(33):18, 20. PubMed ID: 8575701
    [No Abstract]   [Full Text] [Related]  

  • 18. A comparison of cycle control and effect on well-being of monophasic gestodene-, triphasic gestodene- and monophasic desogestrel-containing oral contraceptives. Gestodene Study Group.
    Bruni V; Croxatto H; De La Cruz J; Dhont M; Durlot F; Fernandes MT; Andrade RP; Weisberg E; Rhoa M
    Gynecol Endocrinol; 2000 Apr; 14(2):90-8. PubMed ID: 10836195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the cycle control and tolerability of two ultra low-dose oral contraceptives containing 20 micrograms ethinylestradiol and either 150 micrograms desogestrel or 75 micrograms gestodene.
    Serfaty D; Vree ML
    Eur J Contracept Reprod Health Care; 1998 Dec; 3(4):179-89. PubMed ID: 10036600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of oral estrogen-progestin contraceptives on blood coagulation and assessment of the risk of thromboembolism].
    Surico N; Porcelli A; Petrelli P; Amedeo M; Crivello T; Ferraris G
    Minerva Ginecol; 1988 Sep; 40(9):559-62. PubMed ID: 2975773
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.